CD209 and nasopharyngeal carcinoma: Similarly, Li et al.61proposed that the AA genotype of rs735240 can protect against nasopharyngeal carcinoma by reducing DC-SIGN expression and consequently decreasing the infection of DCs and nasopharyngeal epithelial cells by the Epstein-Barr virus.